Remei P. Blanco
Terrassa, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer.
Journal: Expert opinion on biological therapy
Published: May 20, 2026
Bioethical implications of artifical intelligence in surgery.
Journal: Cirugia espanola
Published: January 20, 2026
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial.
Journal: JAMA oncology
Published: December 15, 2022
Open preperitoneal vs. open anterior repair for the treatment of emergency femoral hernia: a bicentric retrospective study.
Journal: Hernia : the journal of hernias and abdominal wall surgery
Published: May 29, 2022
Open Emergent Groin Hernia Repair: Anterior or Posterior Approach?
Journal: Journal of abdominal wall surgery : JAWS
Published: April 19, 2022
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.
Journal: BMC cancer
Published: January 19, 2022
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.
Journal: BMC cancer
Published: April 14, 2021
Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 02, 2021
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
Journal: JAMA oncology
Published: April 10, 2020
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
Journal: Cancer epidemiology
Published: October 03, 2019
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions.
Journal: Molecular oncology
Published: May 14, 2019
Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.
Journal: Oncotarget
Published: May 10, 2019
Last Updated: 09/26/2026